1. Home
  2. CTSO vs ATCH Comparison

CTSO vs ATCH Comparison

Compare CTSO & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.38

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.18

Market Cap

27.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
ATCH
Founded
1997
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
27.5M
IPO Year
2008
2024

Fundamental Metrics

Financial Performance
Metric
CTSO
ATCH
Price
$0.38
$0.18
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.38
$1.00
AVG Volume (30 Days)
86.7K
1.2M
Earning Date
05-01-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
N/A
EPS
N/A
0.05
Revenue
$22,503,908.00
N/A
Revenue This Year
$10.34
$84.47
Revenue Next Year
$22.41
$39.32
P/E Ratio
N/A
$3.83
Revenue Growth
48.53
N/A
52 Week Low
$0.35
$0.14
52 Week High
$1.22
$1.92

Technical Indicators

Market Signals
Indicator
CTSO
ATCH
Relative Strength Index (RSI) 43.84 45.05
Support Level $0.36 $0.18
Resistance Level $0.74 $0.22
Average True Range (ATR) 0.03 0.01
MACD 0.00 0.00
Stochastic Oscillator 23.00 25.37

Price Performance

Historical Comparison
CTSO
ATCH

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: